Delivery Order 36F79719D0153-36C26021F0236
Award Date 3/1/21
Potential Completion Date 3/1/21
Potential Value $212K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Genzyme Corporation, doing business as Sanofi Genzyme, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $89,094.00 order is for the delivery of various specialty pharmaceutical products, including Eliglustat (Cerdelga), Lemtrada, and Caprelsa (vandetanib), to support treatment programs for veterans. Genzyme...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract to Genzyme Corporation, a division of Sanofi Genzyme, to provide the drug CERDELGA. The contract has a potential value of $106,912.80 and a completion date of March 31, 2019. Genzyme is the prime contractor on this award, which was placed against the company's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple award schedule managed by the VA. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $40,668.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Genzyme Corporation for emergency Caprelsa (vandetanib) medication. Genzyme Therapeutics Division, a division of Sanofi Genzyme, will provide the medication on a firm fixed price basis, with completion by October 30, 2020. The delivery order was awarded on May 28, 2020 under GSA Schedule...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22, is for an emergency pharmaceutical order of 84mg Eliglustat Cerdelga tablets from Genzyme Corporation. The $20,049.02 firm fixed price order issued to Genzyme Therapeutics Division, a division of Sanofi Genzyme, will supply the needed medication to the Veterans Integrated Service Network 22 by...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $124,840.80 delivery order to Genzyme Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for eliglustat/Cerdelga capsules. As the prime contractor, Genzyme Therapeutics Division will deliver the requested pharmaceutical products to a place of performance in Riverwoods, Illinois. No set-aside designation was used for this contract awarded to support...
- This federal contract award is for the delivery of Eliglustat (Cerdelga) 84mg oral capsules to the Puget Sound VA Health Care System. The $144,553.36 firm fixed price delivery order was issued against Genzyme Corporation's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Genzyme Corporation, doing business as Sanofi Genzyme, is the prime contractor for this order, with no set-aside designation...
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Genzyme Corporation, doing business as Sanofi Genzyme, for the pharmaceutical product Eliglustat (Cerdelga 84mg) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) contract. The order has a ceiling value of $246,001.38 and a performance period ending on October 26, 2023. Genzyme serves as the prime contractor, with no set-aside designation applied. This...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $265,045.04 firm fixed price delivery order to Genzyme Corporation, doing business under its Genzyme Therapeutics Division, for eliglustat medication. The period of performance is from October 1, 2020 to September 30, 2021. The delivery order was awarded against Genzyme Corporation's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking...
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics division, was awarded a $81,714.85 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract calls for the delivery of LEMTRADA MED to Cambridge, MA by August 30, 2020. The award utilizes the Pharmaceuticals and Drugs GSA Schedule, a multiple award...
- Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $71,169.70 firm fixed price delivery order against the Pharmaceuticals and Drugs multiple-award schedule held by its parent company, GSA Schedule FSS-61-IB. The contract calls for Genzyme to provide cancer drugs to support programs run by the Department of Veterans Affairs' Veterans Health Administration Veterans Integrated Service Network 16 located in Cary, North...